SciELO - Scientific Electronic Library Online

vol.78 issue2Endothelial function assessment by positron emission tomography in patients with hypercholesterolemiaAccuracy of 64 slice computed tomography angiography in the diagnosis of ischemic coronary artery disease author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand




Related links

  • Have no similar articlesSimilars in SciELO


Archivos de cardiología de México

On-line version ISSN 1665-1731Print version ISSN 1405-9940


LUPI HERRERA, Eulo et al. Clinical-hemodynamic correlation of the NYHA/WHO system in idiopathic pulmonary artery hypertension: Clinical, therapeutic and long-term prognosis implications. Arch. Cardiol. Méx. [online]. 2008, vol.78, n.2, pp.148-161. ISSN 1665-1731.

Background: The most often used functional classification for categorizing the degree of cardiac disability in patients with chronic left ventricular failure is the NYHA/WHO system. In Idiopathic Pulmonary Arterial Hypertension [I-PAH], this system although used, has not been studied in detail regarding pulmonary hemodynamic parameters association and for long-term prognosis in each of the NYHA/WHO classes. Methods: We retrospectively, studied the NYHA/ WHO system in 83 I-PAH patients. Patients were separated according to the response in the acute vasodilator trial in responders [n = 30] and nonresponders [n = 53]. Results: Classes I - II did not represent the minority population for I-PAH patients [58/83 = 60%]. Only mean right atrial pressure [mRAP] and mean pulmonary artery pressure [mPAP] were different among the NYHA/WHO functional classes [p < 0.000 and p < 0.012; respectively]. I-PAH patients class I have the probability to be a responder 12.6 times more [Cl 95.%: 4.59-40.62; p < 0.000]. The long-term mortality for class I patients was 0.%, for class II: 2.%, for class III: 28.% and for class IV: 63.% [p < 0.0001]. The follow-up change for one grade class of the NYHA/WHO classes at four years was noticed only in 20.% of the I-PAH patients. Conclusions: NYHA/WHO classes l-ll did not represent the minority of I-PAH patients population as has been previously considered. Only mRAP and mPAP were different among the NYHA/WHO classes. The NYHA/ WHO system on the basis of mRAP and mPAP allows to separate classes l-ll from III-IV. I-PAH patients class I have 12.6 times more the probability to be a responder and better long-term survival; irrespective of the treatment the prognosis seems to be excellent for this functional class group patients.

Keywords : Idiopathic pulmonary hypertension; NYHA/WHO system; Chronic left ventricular failure.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License